Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis

Translational Research

Volumn 150, Issue 4, 2007, Pages 216-222

  Shui, Hao Ai ^a   Ka, Shuk Man ^b   Yang, Shun Min ^b   Lin, Yuh Feng ^a   Lo, Yi Fen ^a   Chen, Ann ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MARKER; EPITHELIUM HYPERPLASIA; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 34548814444     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.04.003     Document Type: Article

References (26)

1. Benchimol C. Focal segmental glomerulosclerosis: pathogenesis and treatment. Curr Opin Pediatr 15 (2003) 171-180
2. D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 23 (2003) 117-134
3. Nagata M., Horita S., Shu Y., Shibata S., Hattori M., Ito K., et al. Phenotypic characteristics and cyclin-dependent kinase inhibitors repression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis. Lab Invest 80 (2000) 869-880
4. Schwartz M.M., and Lewis E.J. Focal segmental glomerular sclerosis: the cellular lesion. Kidney Int 28 (1985) 968-974
5. Ramirez F., Travis L.B., Cunningham R.J., Cavallo T., Rajarman S., Brouhard B.H., et al. Focal segmental glomerulosclerosis, crescent, and rapidly progressive renal failure. Int J Pediatr Nephrol 3 (1982) 175-178
6. Shu K.H., Lien J.D., Chou G., Yang Y.F., Lu Y.S., and Wang J.Y. Focal segmental glomerulosclerosis with crescent-a case report. Taiwan Yi Xue Hui Za Zhi 85 (1986) 643-648
7. Verani R.R., and Hawkins E.P. Recurrent focal segmental glomerulosclerosis. A pathological study of the early lesion. Am J Nephrol 6 (1986) 263-270
8. Hudkins K.L., Giachelli C.M., Eitner F., Couser W.G., Johnson R.J., and Alpers C.E. Osteopontin expression in human crescentic glomerulonephritis. Kidney Int 57 (2000) 105-116
9. Lan H.Y., Yu X.Q., Yang N., Nikolic-Paterson D.J., Mu W., Pichler R., et al. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int 53 (1998) 136-145
10. Atkins R.C., Nikolic-Paterson D.J., Song Q., and Lan H.Y. Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 7 (1996) 2271-2278
11. Conlon P.J., Butterly D., Albers F., Rodby R., Gunnells J.C., and Howell D.N. Clinical and pathologic features of familial focal segmental glomerulosclerosis. Am J Kidney Dis 26 (1995) 34-40
12. Ka S.M., Rifai A., Chen J.H., Cheng C.W., Shui H.A., Lee H.S., et al. Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant 21 (2006) 288-298
13. Xie Y., Sakatsume M., Nishi S., Narita I., Arakawa M., and Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60 (2001) 1645-1657
14. Endlich N., Sunohara M., Nietfeld W., Wolski E.W., Schiwek D., Kranzlin B., et al. Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress. FASEB J 16 (2002) 1850-1852
15. Masutani K., Tokumoto M., Nakashima H., Tsuruya K., Kashiwagi M., Kudoh Y., et al. Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis. Clin Nephrol 59 (2003) 395-405
16. Suezawa C., Kusachi S., Murakami T., Toeda K., Hirohata S., Nakamura K., et al. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. J Lab Clin Med 145 (2005) 33-40
17. Chandrashekhar Y. Multifunctional role of osteopontin in ventricular remodeling. J Lab Clin Med 145 (2005) 5-8
18. Sadlier D.M., Connolly S.B., Kieran N.E., Roxburgh S., Brazil D.P., Kairaitis L., et al. Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathy. J Biol Chem 279 (2004) 29670-29680
19. Shui H.A., Ka S.M., Lin J.C., Lee J.H., Jin J.S., Lin Y.F., et al. Fibronectin in blood invokes the development of focal segmental glomerulosclerosis in mouse model. Nephrol Dial Transplant 21 (2006) 1794-1802
20. Montinaro V., Hevey K., Aventaggiato L., Fadden K., Esparza A., Chen A., et al. Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int 42 (1992) 341-353
21. Chao T.K., Rifai A., Ka S.M., Yang S.M., Shui H.A., Lin Y.F., et al. The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy. Kidney Int 70 (2006) 283-297
22. Kreisberg J.I., and Karnovsky M.J. Glomerular cells in culture. Kidney Int 23 (1983) 439-447
23. Gang X., Ueki K., Kon S., Maeda M., Naruse T., and Nojima Y. Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy. Am J Kidney Dis 37 (2001) 374-379
24. Kramer A.B., Ricardo S.D., Kelly D.J., Waanders F., van Goor H., and Navis G. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis. J Pathol 207 (2005) 483-492
25. Nakamura H., Kitazawa K., Honda H., and Sugisaki T. Roles of and correlation between alpha-smooth muscle actin, CD44, hyaluronic acid and osteopontin in crescent formation in human glomerulonephritis. Clin Nephrol 64 (2005) 401-411
26. Chen S., Liu Z., Chen H., Zhou H., Wang J., and Li L. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis. Chin Med J (Engl) 115 (2002) 1301-1307